Exogenous and endogenous markers of tumour oxygenation status - Definitive markers of tumour hypoxia?

被引:0
|
作者
Williams, KJ
Parker, CA
Stratford, IJ
机构
来源
基金
英国医学研究理事会;
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypoxia is a physiological abnormality that has been detected in all solid tumours analysed to date. Studies using polarographic needle electrodes have shown an unequivocal link between the extent of tumour hypoxia and poor treatment outcome. The practical limitations of polarographic needle electrodes have warranted investigation into alternative strategies enabling routine assessment of tumour hypoxia in the clinical setting. This review focuses on the clinical evaluation of exogenous and endogenous markers of tumour hypoxia that may fulfil this role.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 50 条
  • [1] Tumour markers
    Faulkner, David
    Meldrum, Cliff
    AUSTRALIAN PRESCRIBER, 2012, 35 (04) : 125 - 128
  • [2] Tumour markers
    Erdenen, Fusun
    ISTANBUL MEDICAL JOURNAL, 2007, 8 (03): : 15 - 19
  • [3] Tumour markers
    Fiebiger, W
    Wiltschke, C
    ACTA MEDICA AUSTRIACA, 2001, 28 (02) : 33 - 37
  • [4] Prediction of tumour hypoxia and radioresistance with nuclear medicine markers
    Chapman, JD
    Coia, LR
    Stobbe, CC
    Engelhardt, EL
    Fenning, MC
    Schneider, RF
    BRITISH JOURNAL OF CANCER, 1996, 74 : S204 - S208
  • [5] Tumour markers - Introduction
    Abelev, GI
    Sell, S
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (02) : 61 - 65
  • [6] Tumour endothelial markers
    Kopczynska, Ewa
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2008, 12 (06): : 255 - 260
  • [7] Tumour markers: An overview
    Malati T.
    Indian Journal of Clinical Biochemistry, 2007, 22 (2) : 17 - 31
  • [8] Tumour markers in malignancies
    Lindblom, A
    Liljegren, A
    BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7232): : 424 - 427
  • [9] Free radical status and tumour markers in gastrointestinal tumours
    Szilvas, A
    Blazovics, A
    Szekely, G
    Feher, J
    EUROPEAN CONGRESS I.H.P.B.A. "BUDAPEST 1999", 1999, : 409 - 412
  • [10] Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia
    Hodgkiss, RJ
    ANTI-CANCER DRUG DESIGN, 1998, 13 (06): : 687 - 702